Chong Lu

Mar 14, 2024 | medrxiv.org | Chen Sun |Chong Lu |Yongjian Zhang |Ling Wang

The authors have declared no competing interest. This work was supported by Shenzhen High-level Hospital Construction Fund, Clinical Research Project of Peking University Shenzhen Hospital (LCYJ2020002, LCYJ2020015, LCYJ2020020, LCYJ2017001). I confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.

Jan 24, 2024 | respiratory-research.biomedcentral.com | Xixi Song |Hui Cai |Wenjun Peng |Ke Chen |Yingying Zeng |Guiping Zhu | +5 more

ReferencesMcCormack FX, Travis WD, Colby TV, Henske EP, Moss J. Lymphangioleiomyomatosis: calling it what it is: a low-grade, destructive, metastasizing neoplasm. Am J Respir Crit Care Med. 2012;186(12):1210–2. Article  PubMed  PubMed Central  Google Scholar  Cai X, Pacheco-Rodriguez G, Fan QY, et al. Phenotypic characterization of disseminated cells with TSC2 loss of heterozygosity in patients with lymphangioleiomyomatosis. Am J Respir Crit Care Med. 2010;182(11):1410–8.

Dec 19, 2023 | mdpi.com | Chong Lu |Jing Xu |Ke Li |Jing Hui Wang

All articles published by MDPI are made immediately available worldwide under an open access license. No specialpermission is required to reuse all or part of the article published by MDPI, including figures and tables. Forarticles published under an open access Creative Common CC BY license, any part of the article may be reused withoutpermission provided that the original article is clearly cited. For more information, please refer tohttps://www.mdpi.com/openaccess.